What Does RSVIGIV Stand For?

RSVIGIV stands for Respiratory Synctial Virus Immune Globulin Intravenous

RSVIGIV, or Respiratory Syncytial Virus Immune Globulin Intravenous, is a therapeutic preparation derived from human plasma, designed to provide passive immunity against Respiratory Syncytial Virus (RSV). It is primarily administered to infants and young children at high risk for severe RSV disease, helping to reduce the incidence and severity of infections. By supplying concentrated antibodies specific to RSV, RSVIGIV plays a critical role in the prevention and management of this viral respiratory illness.